New Insights into Stem Cell Therapy in 2019 by Ingrid Machado / Stem Cell Miami CEO


Ingrid Machado / CEO Stem Cell Miami

The other day a friend asked me what my New Year’s resolution was.  When I told her “communicate better,” she gave me the kind of look that says “There are SO many other things you should be working on!”

I can’t blame my friend—she has the kind of profession that everyone understands.  At parties, when people ask her what she does, she says she’s a lawyer and the questions stop there.  Me?  I tell people I work with stem cells and they follow me for the rest of the evening asking questions.  Don’t get me wrong, I don’t mind the questions.  It’s just that I keep assuming that people know about my field when, in reality, there’s a tremendous amount of misinformation that people have to sort through.

Anyway, I’m writing this on New Year’s Day and I need to get to work on my resolution, so let’s take a few minutes to go over what stem cells are, what they can and cannot do, and what treatments are available.  First of all, stem cells are just a special type of cell that can transform itself into a different type of cell.  In embryos, stem cells become the various cells that make up the body; in adults, stem cells take care of the damage repair and cell turnover that keeps us going.


STEM CELLS: “From Bench-To-Bedside”

There is a medical expression: “from bench-to-bedside”, which in layman’s terms basically means when there is a medical discovery that passes the investigation phase and starts benefiting the actual patients. One of the biggest scientific / medical discoveries that comes to mind, was the amazing discovery of penicillin by British scientist Sir Alexander Fleming, in the summer of 1924 and then its mass production from 1940 to 1945.

With stem cells, something similar is happening at this very moment. Recently, the NIH (National Institute of Health) reported spending 1.5 billion in 2016 (compared to 1.3 billion back in 2015) researching everything surrounding these miraculous cells in different forms, including: autologous, placenta derived, embryonic or IPS (induced). However, there is a tremendous disconnect between those 1.5 billion (not including private institution related research) and what truly reaches the actual / common citizen in relation to that astounding monetary figure. The unfortunate reality is that in the large majority of cases, these immense government funds dedicated for these particular stem cell related research studies have made little or no true direct impact on actual patients and/or in our US communities as a whole.


Available Human Cell Products Approved by the FDA

Several years ago, I started writing this informational column of which I am very proud of, possibly because it has been the first (in a major publications in the US, as well as in local periodicals) where the topic of stem cells and the fascinating new branch of medicine called “Regenerative Medicine” are thoroughly discussed.

However, the public at large knows very little about the wide array of Human Cell related products that are currently available (and also approved by the FDA). So I have created this informative table, in order to better explain / summarize such available products. Please note that I am comparing these products based on their anti-inflammatory properties and also on their ability to regenerate tissue. Furthermore, I have included Cortisone among them, just as a point of reference:


Autologous (you) X X X
Allogeneic (other) X X
Growth Factors XX X XXX XXXX XXXX
Stem cells


Stem Cell Hematopoietic XXX X

* Table Property of StemCell Miami


As I have explained on numerous previous articles, cytokines and growth factors are the ones responsible for controlling / regulating inflammation and thus, key players at reducing pain.


As you can clearly see on this descriptive table, Cortisone provides only minimal amounts of cytokines and delivers zero growth factors. However, PRP (Platelet Rich Plasma) provides an acceptable amount of cytokines and growth factors, but much less than what PLACENTA derived products provide. Of all of the human cell products, the one that provides the least anti-inflammatory properties is the amniotic product, but yet, it still far outperforms the power of Cortisone.


Meanwhile, stem cells from (both from bone marrow and fat) not only provide a huge amount of cytokines and growth factors, but also have the unique ability to provide cells that have the capacity to replicate and transform into new tissue. In addition, these potent / replicated cells are also able to increase the production of more beneficial cytokines and growth factors in order to help reduce pain & inflammation.


In conclusion, I hope this table serves as a suitable guide for you, as well as for many of my medical colleagues, who now use this table as a valuable tool in order to recommend the most suitable Regenerative Medicine type treatment for their patients.


So if you, a family member or friend are interested in receiving Regenerative Medicine treatments, please call StemCell Miami at 305 598-7777 or toll free at 1-855-598-CELL. For more information visit: or watch our numerous testimonial videos on our YouTube channel @Stemcellmiami or also follow us on FB and Twitter. Stem Cell Miami would appreciate any comments on this article or if you want to write directly to the doctor please do so via:







Stem Cells: New treatment option for Fibromyalgia sufferers.

A few weeks ago, I read a thought-provoking article about fibromyalgia and I would like to discuss a bit further about this terrible illness and how Regenerative Medicine and Stem Cell treatments can greatly help patients that suffer from this particular medical condition.

Consistent with what was mentioned in this article, fibromyalgia involves a group of symptoms in which generalized pain is predominant and the patients tend to experience pain in multiple areas of their bodies simultaneously, often also accompanied by constant fatigue and even symptoms of depression.


The Efficacy of Arthroscopy vs. Stem Cells

This week, I would like to comment on an article initially published by the prestigious BMJ (Spanish Journal of Muscles and Bones) in English and also recently in Spanish (by El Nuevo Herald) discussing the controversial topic about the inefficiency of arthroscopy surgery.

Arthroscopy is a very popular operation that attempts to repair the meniscus and damaged cartilage through small incisions with the assistance of a video camera. It is performed more than 700,000 times a year, mostly in the knee. However, about 15 recent medical studies (conducted on more than 1,700 patients) show that the operation does not provide relief or improve joint function and furthermore, shows multiple complications such as infections, which can be very serious. All this at the astronomical cost of more than 3 billion dollars!


Translate »